NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Obesity & Diabetes Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Obesity



Research from Roosevelt Hospital yields new findings on obesity



December 10th, 2007

According to a study from the United States, "An obesity paradox, a ''paradoxical'' decrease in morbidity and mortality with increasing body mass index (BMI), has been shown in patients with heart failure and those undergoing percutaneous coronary intervention. However, whether this phenomenon exists in patients with hypertension and coronary artery disease is not known."

"A total of 22,576 hypertensive patients with coronary artery disease (follow-up 61,835 patient years, mean age 66 +/- 9.8 years) were randomized to a verapamil-SR or atenolol strategy. Dose titration and additional drugs ( trandolapril and/or hydrochlorothiazide) were added to achieve target blood...


Source: Obesity & Diabetes Week (2007-12-10)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login